Table 4.

Adverse events occurring during study period.

Adverse event	Frequency	Resolved at end of trial?
Middle ear effusion (non-infectious)	2/24 (8.2%)	Y
Headache	1/24 (4.1%)	Y
Migraines	1/24 (4.1%)	Y
Nasal congestion	1/24 (4.1%)	Y
Dental infection	1/24 (4.1%)	Y
Throat pain	1/24 (4.1%)	Y
Cold sore	1/24 (4.1%)	Y
Gastroenteritis	1/24 (4.1%)	Y
Nasal allergy	1/24 (4.1%)	Y
Shoulder pain	1/24 (4.1%)	Y

All events are recorded.